Sitagliptin (50mg), Metformin SR 1000 . . . .. ..

Type 2 Diabetes Mellitus (T2DM) has emerged as one of the most common lifestyle-related health conditions in India, affecting millions of adults across urban and rural populations. Managing diabetes effectively requires not only lifestyle modifications such as diet and exercise but also the right combination of medicines to maintain long-term blood sugar control and prevent complications.

ST-GLIPTIN M50/1000 is a scientifically formulated anti-diabetic tablet containing Sitagliptin (50 mg) and Metformin Sustained Release (SR) 1000 mg. This powerful combination targets multiple pathways involved in glucose regulation, making it highly effective for patients who are unable to achieve adequate glycaemic control with single-drug therapy.

By combining a DPP-4 inhibitor (Sitagliptin) with a biguanide (Metformin SR), ST-GLIPTIN M50/1000 helps control fasting and post-meal blood glucose levels while minimizing the risk of hypoglycaemia. The sustained-release formulation of metformin further improves gastrointestinal tolerance, ensuring better patient compliance.

Uses of ST-GLIPTIN M50/1000

ST-GLIPTIN M50/1000 tablets are primarily prescribed for the management of Type 2 Diabetes Mellitus in adults. It is especially useful in patients whose blood sugar levels are not adequately controlled with metformin alone or other oral antidiabetic medicines.

Primary Uses

• Treatment of Type 2 Diabetes Mellitus

• Control of fasting blood glucose levels

• Reduction of postprandial (after-meal) blood sugar spikes

• Long-term glycaemic control to prevent diabetes-related complications

Additional Clinical Benefits

• Suitable for patients with insulin resistance

• Helps delay the need for insulin therapy

• Can be used as part of combination therapy along with diet and exercise

This medicine is not indicated for Type 1 Diabetes or diabetic ketoacidosis.

Benefits of Sitagliptin (50mg) & Metformin SR (1000mg)

The dual-drug formulation of Sitagliptin (50mg), Metformin SR 1000 offers several therapeutic advantages over monotherapy.

1. Dual Mechanism of Action

• Sitagliptin enhances insulin secretion by increasing incretin hormone levels and reduces excess glucagon release.

• Metformin SR decreases glucose production in the liver and improves insulin sensitivity in peripheral tissues.

Together, they provide balanced and sustained glucose control.

2. Effective Glycaemic Control

• Maintains stable blood sugar levels throughout the day

• Controls both fasting and post-meal glucose fluctuations

• Reduces HbA1c levels effectively with consistent use

3. Low Risk of Hypoglycaemia

Unlike sulfonylureas, this combination has a low risk of causing sudden drops in blood sugar, making it safer for long-term use.

4. Improved Gastrointestinal Tolerance

The sustained-release metformin formulation minimizes common side effects like nausea, bloating, and diarrhoea.

5. Weight Neutral Profile

ST-GLIPTIN M50/1000 is generally weight-neutral, which is particularly beneficial for overweight or obese diabetic patients.

6. Better Patient Compliance

Once-daily dosing and improved tolerability help patients adhere to their treatment plan consistently.

Dosage and Administration

The dosage of Sitagliptin (50mg), Metformin SR 1000 should always be individualized based on the patient’s blood glucose levels, previous treatment history, and overall health condition.

Recommended Dosage

• Typically taken once daily, preferably with or after meals

• Should be swallowed whole with water

• Do not crush, chew, or break the tablet

Important Dosage Guidelines

• Always follow your doctor’s prescription

• Dose adjustments may be required in elderly patients

• Regular monitoring of blood sugar and kidney function is advised

Missed Dose:
If a dose is missed, take it as soon as remembered. If it is close to the next scheduled dose, skip the missed dose. Do not double the dose.

Side Effects of ST-GLIPTIN M50/1000

Most patients tolerate Sitagliptin (50mg), Metformin SR 1000 well. However, like all medicines, it may cause some side effects.

Common Side Effects

• Nausea

• Diarrhoea

• Abdominal discomfort

• Headache

• Loss of appetite

These effects are usually mild and tend to subside as the body adjusts to the medication.

Less Common but Serious Side Effects

• Hypoglycaemia (rare when used alone)

• Lactic acidosis (very rare but serious)

• Pancreatitis symptoms (severe abdominal pain)

• Allergic reactions such as rash or itching

Seek immediate medical attention if you experience severe or persistent symptoms.

Warnings

ST-GLIPTIN M50/1000 should be used with caution in certain medical conditions.

Important Warnings

• Not recommended in patients with severe kidney impairment

• Avoid use in patients with metabolic acidosis

• Temporary discontinuation may be required before major surgery or contrast imaging procedures

• Alcohol intake should be limited as it may increase the risk of lactic acidosis

Always inform your doctor about your complete medical history before starting this medication.

Conclusion

ST-GLIPTIN M50/1000 Tablets, containing Sitagliptin 50 mg and Metformin SR 1000 mg, represent an advanced and reliable option for the effective management of Type 2 Diabetes Mellitus. By addressing insulin resistance, enhancing insulin secretion, and reducing glucose production, this combination ensures comprehensive and sustained glycaemic control.

Its favourable safety profile, low risk of hypoglycaemia, and improved gastrointestinal tolerability make it an ideal choice for patients requiring intensified diabetes therapy. When combined with a balanced diet, regular exercise, and routine medical monitoring, ST-GLIPTIN M50/1000 can significantly improve quality of life and reduce the risk of long-term diabetic complications.

Precautions – Frequently Asked Questions (FAQs)

Q1. Can ST-GLIPTIN M50/1000 be taken daily?

Yes, it is intended for daily use as prescribed by a doctor for long-term diabetes management.

Q2. Is this medicine safe for elderly patients?

Yes, but dose adjustment and kidney function monitoring are essential in elderly patients.

Q3. Can ST-GLIPTIN M50/1000 cause weight gain?

No, it is generally weight-neutral and does not promote weight gain.

Q4. Is it safe during pregnancy?

This medicine is not usually recommended during pregnancy. Always consult your doctor.

Q5. Can it be taken with insulin?

In some cases, doctors may prescribe it along with insulin, but close monitoring is required.

Q6. How long does it take to show results?

Blood sugar levels may start improving within a few days, but full benefits are seen with consistent use over weeks.